A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

First, the researchers examined MxA’s antiviral activity against blue fox H5N1 and white mink H5N1 viruses isolated from Finnish fur farms, cat H5N1 virus from Poland, and bovine H5N1 from the US.

H5N1 has been the dominant grouping of strains fueling this past year's outbreaks in the U.S., with different variants of that virus spreading in wild birds, poultry flocks, dairy cattle ...

Scientists found that a moderate dose of MEDI8852, an antibody therapy, effectively protected monkeys against severe H5N1 avian flu.

The Centers for Disease Control and Prevention are monitoring the bird flu situation in the United States. Here's what to ...

A surge in H5N1 virus cases among pets, particularly cats, has raised alarms about raw pet food safety. The virus, devastating bird populations nationwide since 2022, has infected cats through ...

The H5N1 virus has a ways to go before it can successfully jump to humans but that it doesn’t reduce the threat it poses.

It’s the country’s first recorded death attributed to H5N1. The US has previously licensed three H5N1 vaccines for humans, but they’re not available commercially. The government has ...

The Centers for Disease Control announced the first human death from H5N1 avian flu or "bird flu" in the United States on Jan. 6 -- and the illness continues to spread. In a Jan. 6 news release ...

A prophylactic antibody-based immune therapy has been shown to protect monkeys against severe bird flu caused by H1N1.